Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Stada Faces Damages On German Pemetrexed Reversal
Stada Launched ‘At Risk’ Following Invalidity Ruling
Sep 03 2020
•
By
Dean Rudge
Stada is among a few players facing damages following 'at-risk' pemetrexed launches • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin